Roivant Sciences (ROIV) Shares Outstanding (2020 - 2026)

Roivant Sciences (ROIV) has reported Shares Outstanding (Entity) for 7 consecutive years, with $722.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 5.93% year-over-year to $722.7 million; the trailing twelve-month figure through Jun 2026 stood at $722.7 million (up 5.93% YoY), and the FY2026 full-year result was $720.4 million, up 3.51% from the prior year.
• Shares Outstanding (Entity) was little changed at $722.7 million in Q2 2026 per ROIV's latest filing, from $720.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $806.7 million in Q1 2024 and bottomed at $682.2 million in Q2 2025.
• Historically, Shares Outstanding (Entity) has averaged $732.2 million across 5 years, with a median of $721.5 million in 2026.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) soared 214.89% in 2022, then decreased 13.73% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $726.8 million in 2022, then grew by 10.74% to $804.9 million in 2023, then declined by 10.59% to $719.6 million in 2024, then retreated by 1.38% to $709.7 million in 2025, then increased by 1.83% to $722.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $722.7 million, $720.4 million, and $709.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.